Thomas Deljehier

Bordeaux Population Health

Papers

2

Total Citations

27

H-Index

2

About

Thomas Deljehier is a leading researcher in the automation of hospital pharmacy aseptic processes, with a focused expertise in robotic compounding systems for sterile drug preparation. His major contributions center on validating the KIRO® Oncology robot for handling cytotoxic monoclonal antibodies and anti-infectious drugs, demonstrating through simulation programs how excipient formulations impact preparation accuracy. Deljehier’s work also includes a pivotal comparative study of two automation methods—robotic and peristaltic pump systems—against manual compounding. Using Failure Modes Effects and Criticality Analysis (FMECA), he quantified risk reduction, while time-motion analyses revealed significant productivity gains. His 2019 papers, cited 16 and 11 times respectively, provide foundational evidence for adopting automation to enhance safety and efficiency in sterile drug preparation. Deljehier’s research directly addresses critical challenges in hospital pharmacy, offering data-driven solutions that minimize human error and improve patient safety during high-risk compounding procedures.

Research Focus

Key Achievements

2
H-Index
2
Papers
27
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Simulation program of a cytotoxic compounding robot for monoclonal antibodies and anti-infectious sterile drug preparation
16 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Bordeaux Population Health

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago